Figure GPS-16Last year prevalence of amphetamines among all adults (15 to 64 years old), young adults (15 to 34 years old) and for the 15 to 24 years old age group

Notes:

Data are from the most recent national surveys available in each country (see epidemiological tables on population surveys, EMCDDA statistical bulletin).

The age range is from between 15 and 18 to 59 and 64. Variations in age ranges may slightly influence disparities between countries.

Czech Republic: 2002; 18-64 y. n=2526; 18-34 y. n=1002; 18-24 y. n=389

Denmark: 2000; 16-64 y. n=11825; 16-34 y. n=4141; 16-24 y. n=1754

Germany: 2003; 18-59 y. n=8061; 18-34 y. n=3775; 18-24 y. n=1891

Estonia: 2003; 15-64 y. n=; 15-34 y. n=646; 15-24 y. n=329

Greece: 2004; 15-64 y. n=4351; 15-34 y. n=2620; 15-24 y. n=1785

Spain: 2001; 15-64 y. n=14113; 15-34 y. n=6915; 15-24 y. n=3368

France: 2002; 15-64 y. n=1744; 15-34 y. n=724; 15-24 y. n=345

Ireland: 2002/03; 15-64 y. n=4925; 15-34 y. n=; 15-24 y. n=

Italy: 2003; 15-54 y. n=; 15-34 y. n=5231; 15-24 y. n=2112

Latvia: 2003; 15-64 y. n=; 15-34 y. n=; 15-24 y. n=

Hungary: 2003; 18-54 y. n=; 18-34 y. n=2319; 15-24 y. n=943

Netherlands: 2000/01; 15-64 y. n=14045; 15-34 y. n=6687; 15-24 y. n=

Poland: 2002; 16+ y. n=3148; 16-34 y. n=; 16-24 y. n=

Portugal: 2001; 15-64 y. n=14184; 15-34 y. n=6406; 15-24 y. n=3099

Slovakia: 2002; 18-64 y. n=1405; 18-34 y. n=; 18-24 y. n=

Finland: 2002; 15-64 y. n=2377; 15-34 y. n=1240; 15-24 y. n=614

UK (E&W): 2003/04; 16-59 y. n=24422; 16-34 y. n=8590; 16-24 y. n=5429

Norway: 1999; 15-64 y. n=1803; 15-34 y. n=794; 15-24 y. n=

Sources:

Reitox national reports 2004, taken from population surveys reports or scientific articles. See also standard epidemiological tables in EMCDDA statistical bulletin.

Data filter | gpsfig16-en.xml